CROMIE KAREN,DOMBRECHT BRUNO,ETTENBERG SETH,KOLKMAN JOOST,LI JING,MEERSCHAERT KRIS,STOVER DAVID RAYMOND,ZHANG JINGXIN
申请号:
ZA201205864
公开号:
ZA201205864B
申请日:
2012.08.03
申请国别(地区):
ZA
年份:
2013
代理人:
摘要:
The present invention relates to amino acid sequences that are directed against TRAIL cell surface receptor 2 (herein also “DR5”), as well as to compounds or constructs thereof, and in particular proteins and polypeptides and nucleotides that encode them (referred to herein in their entirety as “NB agents”) and fragments thereof, and pharmaceutically effective variants thereof, and their use in the diagnosis and treatment of DR5 associated diseases and disorders.